Abstract:
Objective To analyze the feasibility of labeling MAG3-isoDGR-2C with 99Tcm and investigate the biodistribution of the tracer in normal mice.
Methods Glucoheptonate was initially labeled with 99Tcm as the intermediate, followed by MAG3-isoDGR-2C. High-performance liquid chromatography was employed to determine the radiochemical purity. The biodistribution of 99Tcm-MAG3-isoDGR-2C was studied at 15, 30, 60, 120, 240 and 360 min after caudal vein injection in normal mice.
Results MAG3-isoDGR-2C was successfully labeled with 99Tcm, and the radiochemical purity was 94.2%. The biodistribution revealed that the tracer was rapidly cleared out from the blood with mild activity in the heart, lung, spleen, stomach, and bone.
Conclusions MAG3-isoDGR-2C was labeled with 99Tcm with high radiochemical purity, and the tracer could be cleared out quickly. Therefore, MAG3-isoDGR-2C is a potential molecular tracer in the study of early cancer diagnosis.